OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$9.19
+0.45 (+5.15%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+517.0% upside
Low Target
$44.23
Average Target
$56.70
High Target
$95.28
Current Price
$9.19
Current
$9.19
$9.19
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Scenario Analysis
Bear Case
$44.23
381.3%
Low target
Base Case
$56.70
+517.0%
Avg target
Bull Case
$95.28
+936.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$16.44
-44.1% from high
52-Week Low
$6.23
+47.5% from low
Target vs 52W High
$56.70
+244.9% vs high
Next Earnings Report
Aug 10, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.40
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals